Literature DB >> 21497299

Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro.

Emina Besic Gyenge1, Seraina Hiestand, Susanna Graefe, Heinrich Walt, Caroline Maake.   

Abstract

BACKGROUND: Meso-tetra-hydroxyphenyl-chlorine (mTHPC) is among the most powerful photosensitizers available for photodynamic therapy (PDT). However, the mechanisms leading to cell death are poorly understood. We here focused on changes at DNA and RNA levels after treatment with the liposomal mTHPC derivative Foslipos in vitro.
METHODS: After determination of darktoxicity, laser conditions and uptake kinetics, PC-3 prostate carcinoma cells were subjected to PDT with Foslipos, followed by assessment of cell numbers directly (TP0) or 1h (TP1), 2h (TP2), 5h (TP5) and 24h (TP24) after illumination. Nucleic acids had been extracted for evaluation of RNA amounts and integrity as well as for estimation of abasic sites as a measure for DNA damage. Furthermore, expression changes of 84 genes related to oxidative stress were investigated by quantitative polymerase chain reaction.
RESULTS: Already at TP0, the number of dead cells was significantly higher after PDT versus controls and at TP24 more than 90% of cells had been destroyed. PDT resulted in a severe damage of both RNA and DNA. Gene expression analyses revealed an impact of PDT on pathways for oxidative and metabolic stress, heat shock, proliferation and carcinogenesis, growth arrest, inflammation, DNA repair and apoptosis signaling.
CONCLUSIONS: Mechanisms of Foslipos-mediated PDT comprise a combination of acute and delayed lethal effects in PC-3 cells. The latter may include death processes initiated by nucleic acid damage, activation of stress and growth arrest genes in combination with a reduced capability to adequately cope with oxidative toxicity. Our results will help to better understand molecular photodynamic effects.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497299     DOI: 10.1016/j.pdpdt.2011.02.001

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  4 in total

1.  Type 1 phototherapeutic agents, part I: preparation and cancer cell viability studies of novel photolabile sulfenamides.

Authors:  Amolkumar S Karwa; Amruta R Poreddy; Bethel Asmelash; Tien-Sung Lin; Richard B Dorshow; Raghavan Rajagopalan
Journal:  ACS Med Chem Lett       Date:  2011-09-13       Impact factor: 4.345

2.  Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry.

Authors:  Sandra Vranic; Nicole Boggetto; Vincent Contremoulins; Stéphane Mornet; Nora Reinhardt; Francelyne Marano; Armelle Baeza-Squiban; Sonja Boland
Journal:  Part Fibre Toxicol       Date:  2013-02-06       Impact factor: 9.400

Review 3.  Photosensitizers in prostate cancer therapy.

Authors:  Taher Gheewala; Troy Skwor; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-02

4.  π-π-Stacked Poly(ε-caprolactone)-b-poly(ethylene glycol) Micelles Loaded with a Photosensitizer for Photodynamic Therapy.

Authors:  Yanna Liu; Marcel H A M Fens; Bo Lou; Nicky C H van Kronenburg; Roel F M Maas-Bakker; Robbert J Kok; Sabrina Oliveira; Wim E Hennink; Cornelus F van Nostrum
Journal:  Pharmaceutics       Date:  2020-04-09       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.